Cochrane Abstracts
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lamivudine or Adefovir Dipivoxil Alone or Combined With Immunoglobulin for Preventing Hepatitis B Recurrence After Liver Transplantation." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436341/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation.
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436341/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation. Accessed January 20, 2026.
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436341/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation
Lamivudine or Adefovir Dipivoxil Alone or Combined With Immunoglobulin for Preventing Hepatitis B Recurrence After Liver Transplantation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436341/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
ID - 436341
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436341/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
